Skip to main content
. Author manuscript; available in PMC: 2018 Jun 20.
Published in final edited form as: Am J Perinatol. 2016 Apr 8;33(9):894–902. doi: 10.1055/s-0036-1581080

Table 5.

Multivariate regression model for BPD

BPD (N = 317) No BPD (N = 606) OR (95% CI) p-Value Adjusted OR (95% CI) Model p-value
BW (g) 795 (189) 976 (181) 0.3 (0.2–0.4) < 0.001 0.7a (0.5–0.9) 0.002
GA (wk) 25.9 (1.8) 28.1 (2.1) 0.6 (0.5–0.6) < 0.001 0.8 (0.7–0.9) < 0.001
Race
 White 177 (55.8) 290 (47.9) Ref Ref
 Black 75 (23.7) 150 (24.8) 0.8 (0.6–1.1) 0.24 0.8 (0.5–1.2) 0.20
 Others 65 (20.5) 166 (27.4) 0.6 (0.5–0.9) 0.01 0.8 (0.5–1.1) 0.17
MV ≥ 48 h 270 (85.2) 244 (40.3) 8.5 (6.0–12.1) < 0.001 2.1 (1.4–3.3) < 0.001
Any HFVa 157 (49.3) 71 (11.7) 7.4 (5.3–10.3) < 0.001 2.8 (1.9–4.1) < 0.001
Late-onset sepsis 119 (37.5) 93 (15.4) 3.3 (2.4–4.6) < 0.001 1.6 (1.1–2.4) 0.01
CMV positive 14 (4.4) 5 (0.8) 6.4 (2.3–18.0) < 0.001 4.0 (1.3–12.4) 0.02

Abbreviations: BPD, bronchopulmonary dysplasia; BW, birth weight; CI, confidence interval; CMV, cytomegalovirus; GA, gestational age; HFV, high-frequency ventilation; MV, mechanical ventilation; OR, odds ratio; Ref, reference value.

Note: Model includes all infants with birth weight < 1,250 g, born from 2003 to 2013 with clinical status known at 36 weeks CGA (N = 923). Postnatal steroid treatment was given in 37 (11.8%) of BPD patients versus 10 (1.7%) of infants without BPD (p < 0.001). This variable was excluded from the final model due to collinearity with BPD as outcome.

a

Odds ratio for increase per 250 g birth weight.